Hormonal status and the clinical course of ovarian cancer
Livshits, M.A.; Tsyrlina, E.V.; Vasil'eva, I.A.; Lakher, M.B.; Iudkovskaia, I.L.
Akusherstvo i Ginekologiia 12: 29-31
1978
ISSN/ISBN: 0300-9092 PMID: 736229 Document Number: 124301
As a rule, patients with ovarian cancer do not display any important endocrine disturbances. The authors studied the cases of 104 of these patients: 19 had benign tumors, 6 intermediate tumors, 6 had 1st stage ovarian cancer, 7 3rd stage cancer, 54 4th stage cancer. The remaining patients had a recidivist ovarian cancer. All patients with primary cancer had the uterine hormonal secretions studied. The results indicated the absence of specific changes in the uterine secretion of steroid hormones and in the level of follicle stimulating hormone and luteinizing hormone in the serum. This was true for all patients with benign, intermediate and malignant ovarian tumors. The duration of remission in the patients with 4th stage of cancer was greater when the estrogen stimulation and the level of androgen secretion were increased.